METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS Russian patent published in 2024 - IPC A61K31/00 A61K31/137 A61K31/58 A61K9/08 A61K9/12 A61P11/00 A61P31/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to phthisiology, and can be used in treating patients with pulmonary tuberculosis. In case of multiple drug resistance, a chemotherapy regimen is used for period of 18 months in the amount of: Bedaquiline 0.4 mg once day for 14 days, then 0.2 mg 3 times a week: monday, wednesday, friday, Linezolid 0.6 mg once a day, Moxifloxacin 0.4 mg once a day, Cycloserine 0.25 mg 3 times a day, Amikacin 1.0 g once a day, Pyrazinamide 0.5 mg 3 times a day. Inhalation therapy is carried out in parallel with anti-tuberculosis therapy for a period of time until regression of the tuberculosis process in the bronchi in the amount of: Dioxydin 1.5 ml + 2.0 ml of physiological solution 2 times a day through a nebuliser, Pulmicort 0.5 mg 2 times a day through a nebuliser.

EFFECT: invention provides a wider range of technical means which can be used to treat patients with pulmonary tuberculosis, as well as higher clinical effectiveness in such patients.

1 cl, 3 dwg, 2 ex